371 / 1498
Which Patients with Stage I-II Hodgkin Lymphoma for
Contemporary Combined Modality Therapy in PET era ?
• As a treatment option for patients with favorable disease,
especially when risk late toxicity of RT considered lower
than risk of relapse (Age, site of disease, sex)
• Older patients –risks associated with ABVD
• Definitely for patients with a positive interim PET scan
(~25%)
• Definitely for patients with large mediastinal adenopathy -
female patients ?